US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Terns Pharmaceuticals Inc (TERN)
Terns Pharmaceuticals Inc (TERN) ニュース

TERN

Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TERN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/18	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/05/14	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/05/13	21 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/05/13	21 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/05/09	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Announces Leadership Changes	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/05/08	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/05/04	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/04/30	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/04/11	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/03/15	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/03/12	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/03/08	06 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/03/06	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/02/28	06 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/02/16	08 : 02	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/02/14	22 : 57	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/02/08	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/02/08	06 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/02/07	22 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/02/03	06 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/01/26	09 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/01/05	06 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:TERN	Terns Pharmaceuticals Inc
2024/01/04	06 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:TERN	Terns Pharmaceuticals Inc
2023/11/30	06 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit	NASDAQ:TERN	Terns Pharmaceuticals Inc
2023/11/28	06 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer	NASDAQ:TERN	Terns Pharmaceuticals Inc
2023/11/14	22 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Updates	NASDAQ:TERN	Terns Pharmaceuticals Inc
2023/11/13	22 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023	NASDAQ:TERN	Terns Pharmaceuticals Inc
2023/11/09	22 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences	NASDAQ:TERN	Terns Pharmaceuticals Inc
2023/11/04	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:TERN	Terns Pharmaceuticals Inc
2023/11/03	05 : 05	GlobeNewswire Inc.	Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of Obesity	NASDAQ:TERN	Terns Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:TERN

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Sterling

US Dollar vs Yen

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

Health Care Select Sector

American Express

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約